PATENT CLAIM ANALYSIS

Application Number: 15767131
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "480000"]

Abstract:
The present invention relates to a pharmaceutical composition comprising linagliptin or a pharmaceutically acceptable salt thereof as active ingredient, wherein the pharmaceutical composition does not comprise a binder and wherein the pharmaceutical composition is obtained by direct compression.

Claim (Index 4):
Pharmaceutical composition according to  claim 3 , wherein anhydrous calcium hydrogen phosphate is the only diluent present in the composition.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 91.0
- Lexical Diversity: 1.25
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14417992', '14382499', '14115880', '12238328', '13322536']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7341000906202232
- 35 USC 102 Novelty (BERT): 0.4978743200109912
- Combined Prediction Score: 0.7104775135593
- Mean Citation Score: 200.347742
- Max Citation Score: 242.94351
- Similarity Product: 180.2678599078685

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test